US Patent 7119089 Phenothiazine kinesin inhibitors
Patent 7119089 was granted and assigned to Cytokinetics on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jeffrey T. Finer0
John C. Chabala0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+292 characters)
Article
Patent abstract
Phenothiazine derivatives of formula (I) are disclosed. The compounds are inhibitors of the mitotic kinesin KSP and are useful in the treatment of cellular proliferative diseases, such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation.
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07119089 Phenothiazine kinesin inhibitors US Patent 7119089 Phenothiazine kinesin inhibitors
Infobox
Patent Number
071190890
Patent Number
71190890
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071190890
Date of Patent
October 10, 2006
0Patent Application Number
112272860
Date Filed
September 16, 2005
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07119089 Phenothiazine kinesin inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07119089
Date of patent
October 10, 2006
Patent application number
11227286
Date Filed
September 16, 2005
Patent primary examiner
Find more entities like US Patent 7119089 Phenothiazine kinesin inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.